These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30002072)

  • 1. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
    Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
    Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
    Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
    Hamzah F; Shinojima A; Mori R; Yuzawa M
    BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A; Daruich A; Zola M; Behar-Cohen F
    Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y; Li X; Gong Y
    Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
    Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
    Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
    Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
    Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal vessel diameter in central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population.
    Arora S; Pyare R; Sridharan P; Arora T; Thakar M; Ghosh B
    Indian J Ophthalmol; 2016 Oct; 64(10):747-751. PubMed ID: 27905337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
    Çiloğlu E; Unal F; Dogan NC
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
    Song IS; Shin YU; Lee BR
    Am J Ophthalmol; 2012 Aug; 154(2):366-375.e4. PubMed ID: 22633348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.
    Yang J; Wang E; Yuan M; Chen Y
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy?
    Ulaş F; Uyar E; Tekçe H; Çelebi S
    Semin Ophthalmol; 2019; 34(7-8):533-540. PubMed ID: 31646925
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Son BK; Kim K; Kim ES; Yu SY
    Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
    Bae K; Nam SW; Kang SW; Kim ES; Yu SY; Kim KT; Kim SJ
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):279-288. PubMed ID: 30564905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
    Dysli C; Berger L; Wolf S; Zinkernagel MS
    Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.